![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 21, 15629-15636, May 26, 2000
From the We have previously shown that
-Melanocyte-stimulating Hormone Reduces Impact of
Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on
Keratinocyte and Melanoma Cell Lines*
§,
,
,
,
,
University Section of Medicine, Division of
Clinical Sciences, Northern General Hospital,
Sheffield S5 7AU, United Kingdom, ¶ Department of Clinical
Chemistry, Northern General Hospital,
Sheffield S5 7AU, United Kingdom,
Laboratory of Oncology and
Experimental Surgery, Institut Bordet, Université Libre de
Bruxelles, B-1000 Brussels, Belgium, and the ** University Department
of Opthalmology and Orthoptics, Royal Hallamshire Hospital,
Sheffield, S10 2JF, United Kingdom
-melanocyte-stimulating hormone (
-MSH) can oppose tumor necrosis
factor
activation of NF-
B (1-2 h) and intercellular adhesion
molecule 1 up-regulation (mRNA by 3 h and protein by 24 h) in melanocytes and melanoma cells. The present study reports on the
ability of four MSH peptides to control intracellular peroxide levels
and glutathione peroxidase (GPx) activity in pigmentary and
nonpigmentary cells. In human HBL melanoma and HaCaT keratinocytes
tumor necrosis factor
and H2O2 both
activated GPx in a time- and concentration-dependent manner
(by 30-45 min).
-MSH peptides were found to inhibit the stimulated
GPx activity and had biphasic dose-response curves. MSH 1-13 and MSH
[Nle4-D-Phe7] achieved maximum
inhibition at 10
10 and 10
12 M,
respectively. Higher concentrations (10-100 fold) of MSH 4-10 and MSH
11-13 were required to produce equivalent levels of inhibition.
-MSH was also capable of reducing peroxide accumulation within 15 min, and again this inhibition was biphasic. The data support a role of
-MSH in acute protection of cells to oxidative/cytokine action that
precedes NF-
B and GPx activation. The rapidity and potency of the
response to
-MSH in pigmentary and nonpigmentary cells suggest this
to be a central role of this peptide in cutaneous cells.
*
This work was supported by registered Charity No. 226678, Grant 87762 from the Special Trustees for the Former United Sheffield Hospitals, Sheffield, UK.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
M. T. Landi, P. A. Kanetsky, S. Tsang, B. Gold, D. Munroe, T. Rebbeck, J. Swoyer, M. Ter-Minassian, M. Hedayati, L. Grossman, et al. MC1R, ASIP, and DNA Repair in Sporadic and Familial Melanoma in a Mediterranean Population J Natl Cancer Inst, July 6, 2005; 97(13): 998 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bohm, I. Wolff, T. E. Scholzen, S. J. Robinson, E. Healy, T. A. Luger, T. Schwarz, and A. Schwarz {alpha}-Melanocyte-stimulating Hormone Protects from Ultraviolet Radiation-induced Apoptosis and DNA Damage J. Biol. Chem., February 18, 2005; 280(7): 5795 - 5802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Steinhoff, S. Stander, S. Seeliger, J. C. Ansel, M. Schmelz, and T. Luger Modern Aspects of Cutaneous Neurogenic Inflammation Arch Dermatol, November 1, 2003; 139(11): 1479 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Yoon, S.-H. Goh, J.-S. Chun, E.-W. Cho, M.-K. Lee, K.-L. Kim, J.-J. Kim, C.-J. Kim, and H. Poo {alpha}-Melanocyte-stimulating Hormone Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-{alpha} Production in Leukocytes by Modulating Protein Kinase A, p38 Kinase, and Nuclear Factor {kappa}B Signaling Pathways J. Biol. Chem., August 29, 2003; 278(35): 32914 - 32920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Hassoun, L. Zou, F. A. Moore, R. A. Kozar, N. W. Weisbrodt, and B. C. Kone alpha -Melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol, June 1, 2002; 282(6): G1059 - G1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-w. Jeong, M.-H. Yoo, T. S. Kim, J.-H. Kim, and I. Y. Kim Protection of Mice from Allergen-induced Asthma by Selenite. PREVENTION OF EOSINOPHIL INFILTRATION BY INHIBITION OF NF-kappa B ACTIVATION J. Biol. Chem., May 10, 2002; 277(20): 17871 - 17876. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Scott, K. Wakamatsu, S. Ito, A. L. Kadekaro, N. Kobayashi, J. Groden, R. Kavanagh, T. Takakuwa, V. Virador, V. J. Hearing, et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation J. Cell Sci., January 6, 2002; 115(11): 2349 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Abdel-Malek, M. Scott, M Furumura, M. Lamoreux, M Ollmann, G. Barsh, and V. Hearing The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes J. Cell Sci., January 3, 2001; 114(5): 1019 - 1024. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |